Intrinsic Value of S&P & Nasdaq Contact Us

SCP & Co. Healthcare Acquisition Company SHACU NASDAQ

NASDAQ Capital Marke • Financial Services • Shell Companies • US • USD

SharesGrow Score
58/100
1/4 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

SCP & Co. Healthcare Acquisition Company (SHACU) trades at a trailing P/E of 14.4. Trailing earnings yield is 6.96%.

Criteria proven by this page:

  • VALUE (85/100, Pass) — P/E is below market average (14.4); earnings yield beats bond yields (6.96%).
  • Trailing Earnings Yield 6.96% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income.

Overall SharesGrow Score: 53/100 with 1/7 criteria passed.

SharesGrow 7-Criteria Score
58/100
SG Score
View full scorecard →
VALUE
85/100
Price-to-Earnings & upside
Proven by this page
FUTURE
N/A
No coverage
~
PAST
50/100
→ Income
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
MOAT
28/100
→ Income
GROWTH
N/A
No coverage
INCOME
N/A
No coverage

Valuation Snapshot — SHACU

Valuation Multiples
P/E (TTM)14.4
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.00
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.70
Book Value / Share$0.00
Revenue / Share$0.00
FCF / Share$0.00
Yields & Fair Value
Earnings Yield6.96%
Dividend Yield0.00%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2020 $0.00 $0.00 $0.00 -
2021 $0.70 $0.00 $19.04M -
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message